Ensuring Patient Access to Medication

Updated on Thursday, August 25, 2016

Atlanta Allergy & Asthma News
Many of you have seen the recent media coverage concerning the rising cost of EpiPen, the brand name for a product that delivers the drug epinephrine which can be life-saving in the event of a severe allergic reaction. If you are a family with a member who has been prescribed an EpiPen, you might have already experienced this cost increase first-hand.

As Georgia’s largest allergy and asthma practice, Atlanta Allergy & Asthma treats many children and adults who have been diagnosed with severe allergies that put them at risk for a potentially life-threatening allergic reaction known as anaphylaxis. The most common anaphylactic reactions are to foods and insect stings.

It is important to note that if you have been diagnosed with a condition that puts you at risk for anaphylaxis, you should see a board-certified allergist to ensure proper diagnosis and an appropriate management plan. If you have received a prescription for injectable epinephrine, you should be managed by a physician who specializes in the diagnosis and treatment of allergic diseases, which is an allergist.

Every day we work with our patients to help them get access to the medications they need, including injectable epinephrine. We are monitoring this situation and will work with Mylan, the company that produces EpiPen, as we do with all pharmaceutical companies, to ensure our patients have access to the medications they need. As of Thursday, Aug. 25, 2016, Mylan announced a series of steps that is says will make EpiPen more affordable for some patients.

If we can assist you in any way, please contact us via your Patient Portal, or call your Atlanta Allergy & Asthma office.